REPORT ID 20809

Global Peptide Synthesis Market 2017

Publish Date
17-May
Pages
126
Format
Electronic (PDF)

This report studies the Peptide Synthesis market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Peptide Synthesis market by product type and applications/end industries.

The global Peptide Synthesis market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. 

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Peptide Synthesis.

Europe also play important roles in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.

The major players in global Peptide Synthesis market include 
Genescript
GeneArt (Thermofischer)
IDT
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
 
			   
1 Peptide Synthesis Market Overview
1.1 Peptide Synthesis Product Overview
1.2 Peptide Synthesis Segment by Types (Product Category)
1.2.1 Global Peptide Synthesis Sales and Growth (%) Comparison by Types (2012-2022)
1.2.2 Global Peptide Synthesis Sales Market Share (%) by Types in 2016
1.2.3 C Terminal
1.2.4 N Terminal
1.3 Global Peptide Synthesis Segment by Applications
1.3.1 Global Peptide Synthesis Sales (K AA) Comparison by Applications (2012-2022)
1.3.2 Commercial
1.3.3 Academic Research
1.4 Global Peptide Synthesis Market by Regions (2012-2022)
1.4.1 Global Peptide Synthesis Market Size and Growth (%) Comparison by Regions (2012-2022)
1.4.2 North America Peptide Synthesis Status and Prospect (2012-2022)
1.4.3 Asia-Pacific Peptide Synthesis Status and Prospect (2012-2022)
1.4.4 Europe Peptide Synthesis Status and Prospect (2012-2022)
1.4.5 South America Peptide Synthesis Status and Prospect (2012-2022)
1.4.6 Middle East and Africa Peptide Synthesis Status and Prospect (2012-2022)
1.5 Global Peptide Synthesis Market Size (2012-2022)
1.5.1 Global Peptide Synthesis Revenue (Million USD) Status and Outlook (2012-2022)
1.5.2 Global Peptide Synthesis Sales (K AA) Status and Outlook (2012-2022)
2 Global Peptide Synthesis Market Competition by Manufacturers/Brand
2.1 Global Peptide Synthesis Sales (K AA) and Share by Manufacturers (2012-2017)
2.2 Global Peptide Synthesis Revenue (Million USD) and Share by Manufacturers (2012-2017)
2.3 Global Peptide Synthesis Average Price (USD/AA) by Manufacturers (2012-2017)
2.4 Manufacturers Peptide Synthesis Manufacturing Base Distribution, Sales Area, Product Types
2.5 Peptide Synthesis Market Competitive Situation and Trends
2.5.1 Peptide Synthesis Market Concentration Rate
2.5.2 Peptide Synthesis Market Share (%) of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Peptide Synthesis Sales (K AA), Revenue (Million USD) by Regions (2012-2017)
3.2 Global Peptide Synthesis Sales (K AA) and Market Share (%) by Regions (2012-2017)
3.3 Global Peptide Synthesis Revenue (Million USD) and Market Share (%) by Regions (2012-2017)
3.3 Global Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA) and Gross Margin (%) (2012-2017)
3.5 North America Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA) and Gross Margin (%) (2012-2017)
3.6 Europe Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA) and Gross Margin (%) (2012-2017)
3.7 Asia-Pacific Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA) and Gross Margin (%) (2012-2017)
3.8 South America Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA) and Gross Margin (2012-2017)
3.9 Middle East and Africa Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA) and Gross Margin (%) (2012-2017)
4 Global Peptide Synthesis Sales, Revenue, Price Trend by Types
4.1 Global Peptide Synthesis Sales (K AA) and Market Share (%) by Types (2012-2017)
4.2 Global Peptide Synthesis Revenue and Market Share (%) by Types (2012-2017)
4.3 Global Peptide Synthesis Price (USD/AA) by Type (2012-2017)
4.4 Global Peptide Synthesis Sales Growth by Type (2012-2017)
5 Global Peptide Synthesis Market Analysis by Applications
5.1 Global Peptide Synthesis Sales (K AA) and Market Share (%) by Applications (2012-2017)
5.2 Global Peptide Synthesis Sales Growth Rate (%) by Applications (2012-2017)
6 Global Peptide Synthesis Manufacturers Profiles/Analysis
6.1 Genescript
6.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.1.2 Peptide Synthesis Product Category, End Uses and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Genescript Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.1.4 Main Business/Business Overview
6.2 GeneArt (Thermofischer)
6.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.2.2 Peptide Synthesis Product Category, End Uses and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GeneArt (Thermofischer) Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.2.4 Main Business/Business Overview
6.3 IDT
6.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.3.2 Peptide Synthesis Product Category, End Uses and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 IDT Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.3.4 Main Business/Business Overview
6.4 DNA 2.0 (ATUM)
6.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.4.2 Peptide Synthesis Product Category, End Uses and Specification
6.4.2.1 Product A
6.4.2.2 Product A
6.4.3 DNA 2.0 (ATUM) Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.4.4 Main Business/Business Overview
6.5 OriGene
6.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.5.2 Peptide Synthesis Product Category, End Uses and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 OriGene Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.5.4 Main Business/Business Overview
6.6 BBI
6.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.6.2 Peptide Synthesis Product Category, End Uses and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 BBI Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Genewiz
6.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.7.2 Peptide Synthesis Product Category, End Uses and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Genewiz Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eurofins Genomics
6.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.8.2 Peptide Synthesis Product Category, End Uses and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eurofins Genomics Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Gene Oracle
6.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.9.2 Peptide Synthesis Product Category, End Uses and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Gene Oracle Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.9.4 Main Business/Business Overview
6.10 SBS Genetech
6.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.10.2 Peptide Synthesis Product Category, End Uses and Specification
6.10.2.1 Type A
6.10.2.2 Type B
6.10.3 SBS Genetech Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA), Gross Margin (%) and Market Share (%) (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bio Basic
7 Peptide Synthesis Manufacturing Cost Analysis
7.1 Peptide Synthesis Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Peptide Synthesis Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Peptide Synthesis Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Peptide Synthesis Market Forecast (2017-2022)
11.1 Global Peptide Synthesis Sales (K AA), Revenue (Million USD) Forecast (2017-2022)
11.1.1 Global Peptide Synthesis Sales (K AA) and Growth Rate (%) Forecast (2017-2022)
11.1.2 Global Peptide Synthesis Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
11.1.3 Global Peptide Synthesis Price and Trend Forecast (2017-2022)
11.2 Global Peptide Synthesis Sales (K AA) and Revenue (Million USD) Forecast by Regions (2017-2022)
11.2.1 North America Peptide Synthesis Sales (K AA) and Revenue (Million USD) Forecast (2017-2022)
11.2.2 Europe Peptide Synthesis Sales (K AA) and Revenue (Million USD) Forecast (2017-2022)
11.2.3 Asia-Pacific Peptide Synthesis Sales (K AA) and Revenue (Million USD) Forecast (2017-2022)
11.2.4 South America Peptide Synthesis Sales (K AA) and Revenue (Million USD) Forecast (2017-2022)
11.2.5 Middle East and Africa Peptide Synthesis Sales (K AA) and Revenue (Million USD) Forecast (2017-2022)
11.3 Global Peptide Synthesis Sales (K AA), Revenue (Million USD), Price (USD/AA) Forecast by Type (2017-2022)
11.4 Global Peptide Synthesis Sales (K AA) Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List